ACM Research's flat ROCE and increased capital employed suggest it's not investing in high return ventures. Despite this, market optimism remains due to significant past stock returns. However, current trends don't promise high future returns.
Despite EPS growth outpacing share price increase, market enthusiasm for the stock seems muted. The company's recent 62% total shareholder return, higher than the 39% annualized return over half a decade, hints at business momentum.
ACM Research's future profit outlook isn't fully reflected in the current share price, indicating it's not too late to buy ACMR. Investors should also consider other factors like the strength of its balance sheet.
ACM Research's P/E ratio is not growing despite strong performance, possibly indicating expectations of deteriorating earnings. Predicted growth lower than market's may present a risk. Holders may face disappointment if P/E aligns with growth outlook.
joe black8 :
criminal investigation, means money laundering. Amat sells to China launders the money which reflects on earnings. Hence earnings are not what they seem to be without illegal profits from selling to China
Market sentiment toward the stock grows cautious. Positive buzz around the company hints at potential business momentum. However, there are notable warning signs in investment analysis.
ACM Research股票讨论区
2017年上市,主要做晶元清洗设备业务,97%的市场在中国内地,当前价格32.71。
5年来营收持续增长,平均增速49.4%,营业利润平均增速71.4%,净利润平均增速71.3%。2022年起利息费用转为利息收入,没有利息负担。毛利率近5年从47.1%提升到49.5%,净资产收益率从25.2%下降到5.8%,2023年重新提升到10.7%。
5年来资产负债率从55.3%下降到37.9%,应收和存货的比例和增速很不正常。
存货近3年每年增加1.5亿左右,但是近3年净利润从0.43亿提高到0.97亿,没有一年超过1亿,目前5.5亿存货几乎相当于2023年5.6亿的营收。
应收款项近3年累计增长2.6亿,而近3年净利仅有1.9亿,这点从近3年现金流经营净额大幅净流出也能看出。
这两个数据足以说明公司运营有很大问题,暂时缺乏投资价值。
Here is the first major support level I was talking about.
$应用材料(AMAT.US)$
$ACM Research(ACMR.US)$$GlobalFoundries(GFS.US)$$AXT Inc(AXTI.US)$$iShares费城交易所半导体ETF(SOXX.US)$$3倍做多半导体ETF-Direxion(SOXL.US)$$3倍做空半导体ETF-Direxion(SOXS.US)$$INVESCO PHLX SEMICONDUCTOR ETF(SOXQ.US)$
Entry price ?
暂无评论